This is a routine leadership restructuring with no immediate financial catalyst. Monitor upcoming quarterly filings for any changes in operational performance or strategic direction under the new CEO.
Price Chart
Executive Summary
BioHarvest Sciences announced a strategic leadership transition: co-founder and executive chairman Dr. Zaki Rakib has assumed the role of CEO, consolidating R&D, manufacturing, and operations under the CDMO division. Former CEO Ilan Sobel has moved to the board of directors to focus on the D2C business. The filing is a routine management change with no material financial data or guidance provided.
Key Facts
- Dr. Zaki Rakib, co-founder and executive chairman, has become CEO effective April 29, 2026.
- Ilan Sobel, CEO since 2020, has transitioned to the board of directors to focus on D2C growth.
- The company reported approximately $35 million in revenue for fiscal year 2025, up from pre-revenue in 2020.
- No financial guidance, earnings, or material financial data were provided in the filing.
Financial Impact
No financial impact disclosed; revenue figure of ~$35M for FY2025 is historical and not new.
Risk Factors
- Execution risk from leadership transition and consolidation of R&D/manufacturing/operations.
- No updated financial guidance provided, leaving uncertainty about near-term growth trajectory.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 5 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 6-K Filing (Primary) | 0001723464-26-000016 |
| Document: bhsc_ex991.htm | 0001723464-26-000016 |
| Document: 0001723464-26-000016-index-headers.html | 0001723464-26-000016 |
| Document: 0001723464-26-000016-index.html | 0001723464-26-000016 |
| Document: 0001723464-26-000016.txt | 0001723464-26-000016 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 13, 2026 13d ago | 6-K | $1.75 $1.67 | ▼ −4.18% | ▼ −4.64% | $1.68 (−3.44%) |
Oct 8, 2026 19d ago | 6-K | $1.50 $1.70 | ▲ +13.71% | ▲ +13.99% | $1.68 (+12.71%) |
Sep 15, 2026 5w ago | 6-K | $1.66 $1.46 | ▼ −12.05% | ▼ −14.61% | $1.68 (+1.51%) |
Sep 14, 2026 6w ago | 6-K | $1.78 $1.51 | ▼ −14.93% | ▼ −17.04% | $1.68 (−5.07%) |
Jul 15, 2026 14w ago | 6-K | $2.85 $2.18 | ▼ −23.51% | ▼ −22.53% | $1.68 (−40.88%) |
Jun 18, 2026 18w ago | 6-K | $3.26 $2.75 | ▼ −15.64% | ▼ −13.98% | $1.68 (−48.31%) |
May 28, 2026 21w ago | 6-K | $3.90 $3.56 | ▼ −8.72% | ▼ −8.67% | $1.68 (−56.79%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.68 (−59.50%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▲ +8.17% | ▲ +7.46% | $1.68 (+59.50%) |
May 14, 2026 23w ago | 6-K | $4.16 $3.82 | ▼ −8.17% | ▼ −7.46% | $1.68 (−59.50%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers